Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Randomized Experiments01:13

Randomized Experiments

6.6K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.6K
Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Blinding01:11

Blinding

2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Hazard Ratio01:12

Hazard Ratio

64
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
64
Ethics in Research01:56

Ethics in Research

22.8K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
22.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The importance of adequate user feedback for developing appraisal tools for evidence synthesis - the case of TACIT (Tool for Addressing Conflicts of Interest in Trials).

Journal of clinical epidemiology·2026
Same author

Measurement of ethnicity in clinical trials: Delphi survey and consensus statement.

BMJ (Clinical research ed.)·2026
Same author

Factors influencing the trustworthiness of non-randomized studies of interventions: a survey of international experts.

BMC medicine·2026
Same author

Protocol for a SPIRIT extension for reporting pragmatic and explanatory trial protocols designed using the PRECIS tool (SPIRIT-PRECIS).

Journal of clinical epidemiology·2026
Same author

SPIRIT 2025 statement: updated guideline for protocols of randomised trials.

Lancet (London, England)·2026
Same author

Unpacking the black box - a questionnaire study of how medical journals identify and manage conflicts of interest of editors and peer reviewers.

Journal of clinical epidemiology·2026

相关实验视频

Updated: May 9, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K

SPIRIT 2025声明:随机试验协议的更新指南

An-Wen Chan1, Isabelle Boutron2,3, Sally Hopewell4

  • 1Department of Medicine, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.

JAMA
|April 28, 2025
PubMed
概括

更新的SPIRIT 2025声明为完整的随机试验方案提供了基于证据的指导. 这确保了对所有利益相关者的透明度,并提高了临床试验设计和报告的质量.

更多相关视频

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.0K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

9.8K

相关实验视频

Last Updated: May 9, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.6K
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.0K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

9.8K

科学领域:

  • 临床试验方法
  • 研究报告标准

背景情况:

  • 随机试验协议对于研究规划,进行和报告至关重要.
  • 现有的协议通常缺乏关键设计和行为元素的完整性.
  • 为了提高协议的完整性,SPIRIT (标准协议项目:干预试验建议) 声明于2013年制定.

研究的目的:

  • 系统地更新随机试验协议中最低项目的SPIRIT建议.
  • 通过结合最新的证据和最佳实践,确保指南保持相关性.

主要方法:

  • 进行了范围审查和证据数据库,以确定SPIRIT 2013检查清单的潜在变化.
  • 包括SPIRIT/CONSORT扩展和其他报告准则的建议.
  • 在3轮的德尔菲调查中,317名参与者和30名专家的共识会议进行了修订.

主要成果:

  • 更新的SPIRIT 2025声明包括34个试验协议的最低项目.
  • 主要变化包括一个新的开放科学部分,加强对危害和干预描述的关注,以及患者/公众参与项目.
  • 一个扩展的检查清单和解释/编制文档已被开发用于实施.

结论:

  • 更新的SPIRIT 2025声明旨在提高随机试验协议的透明度和完整性.
  • 广泛遵守可以使研究人员,参与者,资助者,道德委员会,期刊和政策制定者受益.
  • 这一修订确保了指导与不断变化的研究标准和实践保持一致.